Search Within

Edyta Barbara Brzostowski

Formats
  1. Meeting Abstract (12)
  2. Journal Article (3)
Groups
  1. Department of Pathology and Laboratory Medicine (15)
  2. Department of Medicine (11)
  3. GSK Faculty (11)
  4. Solid Tumor Oncology Division (11)
  5. Human Oncology and Pathogenesis Program (10)
  6. Tow Center for Developmental Oncology (TCDO) (9)

More Groups

People
  1. Marc Ladanyi (8)
  2. Mark Kris (7)
  3. Gregory Riely (5)
  4. Bob Li (4)
  5. Darren Buonocore (4)
  6. Maria Arcila (4)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (4)
  4. 2014 (1)
  5. 2013 (1)
  6. 2012 (1)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Laboratory Investigation (3)
  3. Journal of Molecular Diagnostics (2)
  4. Modern Pathology (2)
  5. Clinical Cancer Research (1)
  6. Human Mutation (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Nature Publishing Group (3)
  3. Elsevier Science, Inc. (2)
  4. Nature Research (2)
  5. American Association for Cancer Research (1)
  6. Elsevier Inc. (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma
    Journal Article

    Zhang, L.; Walsh, M. F.; Jairam, S.; Mandelker, D.; Zhong, Y.; Kemel, Y.; Chen, Y. B.; Musheyev, D.; Zehir, A.; Jayakumaran, G.; more...
    Human Mutation (2020)

    Fulltext@MSK | Save
  • Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers
    Meeting Abstract

    Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
    Meeting Abstract

    Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial
    Meeting Abstract

    Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent molecular alterations in KRAS-mutant lung adenocarcinomas and effects on overall survival
    Meeting Abstract

    Riely, G. J.; Eng, J.; Yu, H. A.; Hsu, M.; Kris, M. G.; Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Systematic evaluation of KRAS mutation detection using an AmpliSeq custom panel and ion torrent sequencing in 113 KRAS-mutated lung cancers
    Meeting Abstract

    Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; Lailler, N.; Cheng, D.; Viale, A.; Yu, H.; Riely, G.; more...
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save
  • Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: Higher susceptibility of women to smoking-related KRAS-mutant cancers
    Journal Article

    Dogan, S.; Shen, R.; Ang, D. C.; Johnson, M. L.; D'Angelo, S. P.; Paik, P. K.; Brzostowski, E. B.; Riely, G. J.; Kris, M. G.; Zakowski, M. F.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Initial results of LC-MAP: An institutional program to routinely profile tumor specimens for the presence of mutations in targetable pathways in all patients with lung adenocarcinoma
    Meeting Abstract

    Kris, M. G.; Lau, C. Y.; Ang, D.; Brzostowski, E.; Riely, G. J.; Rusch, V. W.; Jhanwar, S.; Lash, A.; Zakowski, M. F.; Ladanyi, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save